Symbol Lookup from Yahoo Finance

Trending Tickers

Symbol	Name	Last Price	Change	Change %
NVO	Novo Nordisk A/S	85.00	-18.44	-17.83%
^GSPC	S&P 500	5,930.85	+63.77	+1.09%
^DJI	Dow Jones Industrial Average	42,840.26	+498.02	+1.18%
RUM	Rumble Inc.	7.19	-0.08	-1.10%
XRP-USD	XRP USD	2.33	+0.25	+11.81%
LCID	Lucid Group, Inc.	3.0200	+0.3900	+14.83%
^IXIC	NASDAQ Composite	19,572.60	+199.83	+1.03%
ADA-USD	Cardano USD	0.98	+0.18	+22.48%
NOVO-B.CO	Novo Nordisk B A/S	589.20	-154.00	-20.72%
BONK-USD	Bonk USD	0.00	+0.00	+29.47%
^RUT	Russell 2000	2,242.37	+20.87	+0.94%
LLY	Eli Lilly and Company	767.76	+10.22	+1.35%
QCOM	QUALCOMM Incorporated	152.89	+2.49	+1.66%
VRSN	VeriSign, Inc.	198.84	+5.40	+2.79%
PEPE24478-USD	Pepe USD	0.00	+0.00	+24.49%
DOGE-USD	Dogecoin USD	0.34	+0.06	+19.49%
SUI20947-USD	Sui USD	4.79	+1.13	+30.70%
ETH-USD	Ethereum USD	3,488.20	+295.62	+9.26%
PLTR	Palantir Technologies Inc.	80.55	+6.34	+8.54%
DOT-USD	Polkadot USD	7.57	+1.27	+20.16%
XRP-CAD	XRP CAD	3.35	+0.35	+11.81%
SHIB-USD	Shiba Inu USD	0.00	+0.00	+19.45%
SIRI	SiriusXM Holdings Inc.	23.08	+2.50	+12.15%
SOL-USD	Solana USD	195.41	+14.25	+7.86%
LUNR	Intuitive Machines, Inc.	13.57	+0.79	+6.18%

Related News

Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week

Stocks signaled another rough day of trading on Friday after the House of Representatives voted against a Trump-backed spending bill.

Yahoo Finance 14 hours ago

YM=F

ES=F
Dow, Nasdaq, S&P 500 rise, ending session with weekly losses

All three of the major market indexes (^DJI, ^IXIC, ^GSPC) closed Friday in positive territory by over 1% each, with the real estate sector (XLRE) leading intraday gains. Despite today’s gains, all three of the market averages ended the last full trading week of 2024 in negative territory. Yahoo Finance senior business reporter Ines Ferré joins the Market Domination Overtime team to recap the market action from over the last trading week. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 13 hours ago

^DJI

^IXIC
San Francisco Fed president Mary Daly: We want to finish the inflation fight

San Francisco Fed president Mary Daly tells Yahoo Finance the Fed has further room to push down interest rates to keep the economy growing while still not stoking renewed inflation.

Yahoo Finance 17 hours ago

META

AAPL
Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results

Novo Nordisk stock sinks on news of its newest GLP-1 candidate.

Yahoo Finance 18 hours ago

LLY

JPM
Market decline is about 2025 policy, not shutdown: Strategist

The government faces a potential shutdown if funding agreements aren't reached by Saturday at midnight. Crossmark Global Investments chief market strategist Victoria Fernandez joins Morning Brief to analyze the market decline and its broader implications. "I really think this is not as much about a government shutdown as it is the market kind of recalibrating their thoughts about how easy it's going to be for their new administration coming in to get their policies put through," Fernandez explains. She notes that recent market "excitement" has been driven by hopes for deregulation, reduced deficit spending, and tax cuts, but "now we're seeing already ... that's not going to be as easy as we thought." Regarding investment strategies, Fernandez observes that investors face "a real push and pull" as they weigh fiscal policy, Fed outlooks, and volatility. "There's elements that look inflationary ... but then you have things that are disinflationary," she notes, adding that "it makes it hard to make a long-term outlook." As a result, she advocates for investors to remain "very diversified." For specific sector recommendations, Fernandez highlights opportunities in financials, industrials, and fixed income. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Angel Smith

Yahoo Finance Video 19 hours ago

^DJI

^IXIC
November PCE, govt. shutdown looms, Novo Nordisk: 3 Things

US stock futures (ES=F, NQ=F, YM=F) are slipping Friday morning after the Personal Consumption Expenditures (PCE) price index rose by 2.8% in November, just 0.1% below economists' estimates A government shutdown looms after House Speaker Mike Johnson's (R-La.) bipartisan spending bill was rebuffed by President-elect Donald Trump and Elon Musk, who Trump tapped to co-lead the proposed Department of Government Efficiency (DOGE). Novo Nordisk (NVO) shares dive by over 20% in Friday's pre-market trading after its experimental weight-loss shot CagriSema helped patients lose less weight than anticipated in its clinical trial. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 20 hours ago

NKE

LLY
The sharp reaction to the Fed could be an ominous sign for markets in 2025: Morning Brief

Fed Chair Jay Powell did nothing particularly surprising on Wednesday, but markets reacted sharply. The strong reaction does not portend smooth sailing in the year ahead as the uncertainty Powell referenced arrives.

Yahoo Finance 23 hours ago

^GSPC
Got $1,000? 3 Smart ETFs to Buy Before 2025 Begins.

The S&P 500 is on track to deliver back-to-back years of more than 20% gains, while the tech-heavy Nasdaq-100 index has nearly doubled since the start of 2023. Investors could just buy exchange-traded funds (ETFs) focused on the S&P 500 or Nasdaq-100 in hopes of a continued rally. A potentially big one is falling interest rates, as the Federal Reserve continues to lower the benchmark federal funds rate (even if the pace is slower than expected).

Motley Fool 12 minutes ago

^GSPC
My Top Vanguard Index ETF Pick for 2025

2024 is turning out to be another strong year for the stock market, with the S&P 500 on track for another year of 20%-plus returns. The benchmark index has produced total returns (including dividends) of nearly 25% as of this writing. On a total return basis, it has only had two years of negative returns since the financial crisis of 2008.

Motley Fool 19 minutes ago

^GSPC
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025

When things seem too good to be true on Wall Street, they usually are.

Motley Fool 28 minutes ago

^GSPC

PFE
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off.

Motley Fool 39 minutes ago

LLY

NVO
1 Heavily Diversified Vanguard ETF That Could Outperform the S&P 500 in 2025

This year has been an exceptional one for the markets as the S&P 500 has risen by around 27%. Many growth stocks are trading near or at their highs as well. One ETF that offers significant diversification and that may outperform the S&P 500 next year is the Vanguard Total Stock Market Index (NYSEMKT: VTI).

Motley Fool 59 minutes ago

^GSPC
1 Magnificent S&P 500 Dividend Stock Down 30% to Buy and Hold Forever

This growth stock is selling off on fears of competition from big technology companies like Tesla and Alphabet. It could be time to be greedy and buy shares.

Motley Fool 1 hour ago

UBER

^GSPC
Meet the Top-Performing Stock in the Dow Jones in 2024. It's Soared 163% So Far This Year, and It's My Highest-Conviction Stock to Buy for 2025.

A wave of AI uncertainty and valuation concerns have stopped this highflier in its tracks, but blistering gains could be on the horizon.

Motley Fool 1 hour ago

NVDA

^DJI
History Says the S&P 500 Will Surge in 2025. 2 Unstoppable Stock-Split Stocks to Buy Before It Does.

These investor-favorite stocks have been a boon to shareholders, and the future looks bright.

Motley Fool 2 hours ago

^GSPC

CMG
Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly said the Food and Drug Administration approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. The company said Zepbound, or tirzepatide, is the first and only prescription medicine for adults suffering from this condition. The drug was launched in the U.S. for the treatment of adults with obesity or who are overweight with weight-related comorbidities in November 2023.

The Wall Street Journal 9 hours ago

LLY
Rumble Gets $775 Million Investment From Crypto Firm Tether

Video platform Rumble said it entered an agreement for an investment from the cryptocurrency company Tether.

The Wall Street Journal 10 hours ago

RUM

RUMBW
Crypto giant Tether invests $775 million in Trump-friendly video service Rumble

Tether's move to buy a large stake in Rumble signals its ambitions to expand both its technological and political ambitions.

Fortune 10 hours ago

RUMBW
Qualcomm Prevails on Key Issues in Arm Suit

A Delaware jury ruled that Qualcomm had a valid license to use Arm’s basic chip architecture for central processors it developed with the acquisition of a startup called Nuvia in 2021. The ruling paved the way for Qualcomm to continue selling those chips, which are at the heart of a range of devices including Microsoft Surface laptops. Qualcomm’s stock rose 1.8% in after-hours trading, while Arm’s stock fell 1.7%.

The Wall Street Journal 10 hours ago

QCOM

ARM
Qualcomm Defeats Arm’s Claim Over Chip Design License Breach

(Bloomberg) -- Qualcomm Inc. prevailed at trial against Arm Holdings Plc’s claim that it breached a license for chip technology that the world’s largest maker of mobile-phone processors acquired when it bought a startup in 2021. Most Read from BloombergThe Architects Who Built MiamiReviving a Little-Known Modernist Landmark in BuffaloNew York City’s Historic Preservation Movement Is Having a Midlife CrisisNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNYPD Car Chases Are Becoming Mo

Bloomberg 10 hours ago

QCOM

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Trending Tickers

Related News

Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week

Dow, Nasdaq, S&P 500 rise, ending session with weekly losses

San Francisco Fed president Mary Daly: We want to finish the inflation fight

Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results

Market decline is about 2025 policy, not shutdown: Strategist

November PCE, govt. shutdown looms, Novo Nordisk: 3 Things

The sharp reaction to the Fed could be an ominous sign for markets in 2025: Morning Brief

Got $1,000? 3 Smart ETFs to Buy Before 2025 Begins.

My Top Vanguard Index ETF Pick for 2025

The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

1 Heavily Diversified Vanguard ETF That Could Outperform the S&P 500 in 2025

1 Magnificent S&P 500 Dividend Stock Down 30% to Buy and Hold Forever

Meet the Top-Performing Stock in the Dow Jones in 2024. It's Soared 163% So Far This Year, and It's My Highest-Conviction Stock to Buy for 2025.

History Says the S&P 500 Will Surge in 2025. 2 Unstoppable Stock-Split Stocks to Buy Before It Does.

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Rumble Gets $775 Million Investment From Crypto Firm Tether

Crypto giant Tether invests $775 million in Trump-friendly video service Rumble

Qualcomm Prevails on Key Issues in Arm Suit

Qualcomm Defeats Arm’s Claim Over Chip Design License Breach